Oxford Nanopore raises $140 million
Ryan Cross
Abstract
Ryan Cross
Abstract
The British DNA sequencer company Oxford Nanopore Technologies has raised $140 million from a group of investors. The company sells the MinION, a popular handheld gene sequencer that can be plugged into a laptop to read DNA sequences in remote locations, including aboard the International Space Station. Oxford Nanopore is also introducing a larger, more powerful sequencer called the PromethION, and a small, real-time DNA sequencer called the Flongle that could be used to monitor infectious diseases. The company will use the funds to build a production facility for its sequencers at a U.K. science and business park.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The British DNA sequencer company Oxford Nanopore Technologies has raised $140 million from a group of investors. The company sells the MinION, a popular handheld gene sequencer that can be plugged into a laptop to read DNA sequences in remote locations, including aboard the International Space Station. Oxford Nanopore is also introducing a larger, more powerful sequencer called the PromethION, and a small, real-time DNA sequencer called the Flongle that could be used to monitor infectious diseases. The company will use the funds to build a production facility for its sequencers at a U.K. science and business park.
Key concepts: Minion, Nanopore sequencing, DNA sequencer, Laptop, Nanopore, Computer science, DNA sequencing, DNA